Ng Lai Guan, Mackay Charles R, Mackay Fabienne
Arthritis and Asthma Research Program, The Garvan Institute of Medical Reseach, 384 Victoria St, Sydney, NSW 2010, Australia.
Mol Immunol. 2005 May;42(7):763-72. doi: 10.1016/j.molimm.2004.06.041. Epub 2004 Dec 8.
B cell activating factor belonging to the TNF family (BAFF) and a proliferation-inducing ligand (APRIL) are two members of the TNF ligand superfamily. Studies of BAFF, APRIL and their receptors have highlighted the importance of this ligand/receptor system in regulating B cell homeostasis, tolerance and malignancy. Neutralizing BAFF can inhibit disease progression in animal models of autoimmunity, possibly by reducing survival of autoreactive B cells. In addition, BAFF inhibitors also prevent B lymphoma cell survival and may be useful for the treatment of lymphoid cancers. Recent work suggests that BAFF is also important for T cell activation and differentiation, an aspect that may be critical for the progression of certain autoimmune diseases. Therefore, targeting the BAFF/APRIL system may protect against autoimmunity and lymphoid cancers through the inhibition of pathogenic B and T cell functions.
肿瘤坏死因子家族的B细胞活化因子(BAFF)和增殖诱导配体(APRIL)是肿瘤坏死因子配体超家族的两个成员。对BAFF、APRIL及其受体的研究突出了该配体/受体系统在调节B细胞稳态、耐受性和恶性肿瘤方面的重要性。中和BAFF可抑制自身免疫动物模型中的疾病进展,可能是通过减少自身反应性B细胞的存活来实现的。此外,BAFF抑制剂还可阻止B淋巴瘤细胞存活,可能对治疗淋巴癌有用。最近的研究表明,BAFF对T细胞活化和分化也很重要,这一方面可能对某些自身免疫性疾病的进展至关重要。因此,靶向BAFF/APRIL系统可能通过抑制致病性B细胞和T细胞功能来预防自身免疫和淋巴癌。